Internal carotid artery agenesis (IAA) is a rare congenital anomaly that results in the absence of one or both internal carotid arteries, leading to cerebrovascular accidents and potential complications related to inadequate oxygen and nutrient supply to the brain. The condition may present with a variety of neurological disorders, including developmental delay, epilepsy, and other neurological symptoms. By its nature, ICA may coexist with other vascular developmental anomalies and should be considered when evaluating patients with unclear neurological symptoms.
History of the disease and interesting historical facts
Agenesis of the internal carotid artery was first described in the mid-20th century, when scientists began to identify congenital anomalies of the vascular structure of the brain. In 1955, the first observation of agenesis of the internal carotid artery was recorded, which became a landmark moment in neurology and vascular anatomy. Over time, research continued, and in the 1990s, active work began to study the pathogenesis and clinical manifestations of this condition. Interesting facts are that agenesis can be combined with other anomalies, such as agenesis or dysplasia of small brain structures, as well as with unclear genetic syndromes, which emphasizes a multidisciplinary approach to the diagnosis and treatment of patients.
Epidemiology
The epidemiology of internal carotid artery agenesis shows that the disease occurs with a frequency of 1 in 10,000 - 1 in 25,000 newborns. However, it is worth noting that statistics may vary depending on the geographic region and population. In particular, among patients with various neurological disorders associated with congenital anomalies, agenesis can occur in 5-15% cases. This disease is more often diagnosed in boys, which may also be associated with genetic factors such as chromosomal abnormalities and mutations.
Genetic predisposition to this disease
To date, several genes have been identified that may be involved in the development of internal carotid artery agenesis. In particular, studies have shown an association between lesions on chromosomes 1, 7, and 12 and the development of this disease. Mutations in genes associated with the development of the vascular system, such as certain variants of the NOTCH and VEGFA gene families, may lead to impaired angiogenesis and, as a result, to carotid artery agenesis. Genetic studies are ongoing and may reveal additional factors predisposing to the disease.
Risk factors for the development of this disease
Risk factors for the development of internal carotid artery agenesis may be both external and internal influences. Physical risk factors include:
- Environmental pollution, including chemicals and toxins.
- Radiation in early pregnancy.
- Viral infections such as rubella and cytomegalovirus.
Other possible related factors include:
- Hereditary predisposition.
- Mother's age during pregnancy.
- Poor nutrition, deficiency of vitamins and minerals.
Diagnosis of this disease
Diagnosis of internal carotid artery agenesis requires a multidisciplinary approach. The main symptoms often include neurological deficits, developmental delay, seizures, and a tendency to stroke. Laboratory studies may include blood chemistry to rule out metabolic disorders. Radiologic examinations are key; magnetic resonance imaging (MRI) and computed tomography (CT) allow precise visualization of the vascular anatomy of the brain. Vascular ultrasound examinations may also be ordered. A differential diagnosis is necessary to exclude other vascular anomalies and neurologic conditions.
Treatment
Treatment of internal carotid artery agenesis depends on the clinical presentation and severity of symptoms. General treatment aims to control symptoms and improve the patient's quality of life. Pharmacological treatment may include anticonvulsants to control seizures and anticoagulants to prevent thrombus formation. Surgical treatment may be considered in cases of significant neurological impairment. Other treatments, such as physical therapy and rehabilitation, also play an important role in improving the functional capabilities of patients.
List of medications used to treat this disease
Today, the following drugs are widely used to treat conditions associated with agenesis of the internal carotid artery:
- Lamotrigine (anticonvulsant).
- Levetiracetam (anticonvulsant).
- Aspirin (to prevent blood clots).
- Clonidine (to control blood pressure).
- Atema (in combination with other drugs).
Disease monitoring
Monitoring of patients with internal carotid artery agenesis includes regular neurological examinations and radiological studies to assess the state of the vascular system. Control stages are important for assessing the effectiveness of treatment and adapting therapy. The prognosis of the disease depends on the degree of damage, the presence or absence of complications. Possible complications include strokes, seizures, and cognitive impairment, which requires timely and high-quality care.
Age-related features of the disease
Agenesis of the internal carotid artery can present differently depending on the age of the patient. In newborns and infants, symptoms may be minimal and manifest as developmental delays or seizures. In preschool-aged children, neurological impairment may become more pronounced and significantly affect functional capabilities. In adults, the aggressive form of the disease often leads to strokes and serious neurological disorders, which requires a comprehensive approach to treatment and supportive care.
Questions and Answers
- What is internal carotid artery agenesis? It is a congenital anomaly characterized by the absence of one or both internal carotid arteries, which can lead to insufficient blood supply to the brain.
- What symptoms may be observed with agenesis of the internal carotid artery? Symptoms may include developmental delays, epilepsy, neurological disorders and increased risk of stroke.
- How is this disease diagnosed? Diagnosis includes neurological examinations, MRI, CT and laboratory tests.
- What are the treatments for internal carotid artery agenesis? Treatment may include drug therapy, surgery, physical therapy, and rehabilitation.
- What is the prognosis for patients with this disease? The prognosis varies depending on the extent of the lesion and the presence of complications, but a general approach to treatment and regular monitoring can significantly improve the patient's quality of life.
In conclusion, Dr. Oleg Korzhikov recommends that patients with agenesis of the internal carotid artery pay special attention to preventive examinations and regular health monitoring. “Taking care of your health is the first step to successful treatment. It is necessary to follow the recommendations of the attending physician, monitor your condition and promptly seek medical help if new symptoms occur,” he says. In addition, it is important to consider possible genetic risk factors and, if necessary, consult a geneticist to determine possible tactics for pregnancy and childbirth.
